Drug-Coated Balloon Angioplasty in Clinical Practice for Below-the-Knee, Popliteal, and Crural Artery Lesions Causing Critical Limb Ischemia: 1-Year Results from the Spanish Luminor Registry

Scheller, 2004, Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis, Circulation, 110, 810, 10.1161/01.CIR.0000138929.71660.E0 Sollott, 1995, Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat, J Clin Invest, 95, 1869, 10.1172/JCI117867 Biondi-Zoccai, 2013, Drug-eluting balloons for peripheral artery disease: a meta-analysis of 7 randomized clinical trials and 643 patients, Int J Cardiol, 168, 570, 10.1016/j.ijcard.2013.01.247 Kayssi, 2016, Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs, Cochrane Database Syst Rev, 8, CD011319 Jaff, 2015, Drug-coated balloons to improve femoropopliteal artery patency: rationale and design of the LEVANT 2 trial, Am Heart J, 169, 479, 10.1016/j.ahj.2014.11.016 Krishnan, 2017, Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies, Circulation, 136, 1102, 10.1161/CIRCULATIONAHA.117.028893 Mehrotra, 2017, Paclitaxel-coated balloon for femoropopliteal artery disease, Curr Cardiol Rep, 19, 10, 10.1007/s11886-017-0823-4 Kokkinidis, 2017, Emerging and future therapeutic options for femoropopliteal and infrapopliteal endovascular intervention, Interv Cardiol Clin, 6, 279 Katsanos, 2016, Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability, J Endovasc Ther, 23, 356, 10.1177/1526602815626557 Stabile, 2012, Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis, J Am Coll Cardiol, 60, 1739, 10.1016/j.jacc.2012.07.033 Schmidt, 2011, First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome, J Am Coll Cardiol, 58, 1105, 10.1016/j.jacc.2011.05.034 Liistro, 2013, Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia, Circulation, 128, 615, 10.1161/CIRCULATIONAHA.113.001811 Zeller, 2014, Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial, J Am Coll Cardiol, 64, 1568, 10.1016/j.jacc.2014.06.1198 Zeller, 2015, JACC Cardiovasc Interv, 8, 1614, 10.1016/j.jcin.2015.07.011 Cortese, 2016, Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document, Eur Heart J, 37, 1096, 10.1093/eurheartj/ehv204 Spiliopoulos, 2019, Current evidence of drug-elution therapy for infrapopliteal arterial disease, World J Cardiol, 11, 13, 10.4330/wjc.v11.i1.13 De Labriolle, 2009, Paclitaxel-eluting balloon: from bench to bed, Catheter Cardiovasc Interv, 73, 643, 10.1002/ccd.21895 Uccioli, 2018, Critical limb ischemia: current challenges and future prospects, Vasc Health Risk Manag, 14, 63, 10.2147/VHRM.S125065 Lee, 2018, Outcomes of drug-coated balloons in patients with critical limb ischemia, J Vasc Surg, 68, e57, 10.1016/j.jvs.2018.06.046 Rocha Singh, 2007, Performance goals and endpoints assessment for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease, Catheter Cardiovasc Interv, 69, 910, 10.1002/ccd.21104 Schmidt, 2016, Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry, JACC Cardiovasc Interv, 9, 715, 10.1016/j.jcin.2015.12.267 Tepe, 2019, Drug-coated balloon treatment for femoropopliteal artery disease: the chronic total occlusion cohort in the IN.PACT global study, JACC Cardiovasc Interv, 12, 484, 10.1016/j.jcin.2018.12.004 Thieme, 2018, Lutonix® 014 DCB global below the knee registry study: interim 6-month outcomes, J Cardiovasc Surg (Torino), 59, 232 Steiner, 2016, Single-center experience with Lutonix drug-coated balloons in infrapopliteal arteries, J Endovasc Ther, 23, 417, 10.1177/1526602816645080 Palena, 2018, Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia, Cardiovasc Revasc Med, 19, 83, 10.1016/j.carrev.2017.06.006 Sigala, 2018, Prognostic factors in patients treated with drug-coated balloon angioplasty for symptomatic peripheral artery disease, Vasc Specialist Int, 34, 94, 10.5758/vsi.2018.34.4.94